Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2019/20 parent results

May 14 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             6.01            15.62                                
                 (-61.5 pct)    (+115.7 pct)                             
  Operating         4.13            13.68                                
                 (-69.8 pct)    (+141.1 pct)                             
  Recurring         4.08            13.63                                
                 (-70.1 pct)    (+143.0 pct)                             
  Net               3.10            30.28                                
                 (-89.8 pct)    (+447.2 pct)                             
  EPS             38.81 yen      379.01 yen                              
  EPS Diluted     38.77 yen      378.66 yen                              
  Ann Div        110.00 yen      120.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         60.00 yen       70.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news